Chronic kidney disease and the global NCDs agenda
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
2017 is an important year for the international nephrology community. March 9 was World Kidney Day, the theme this year being ‘Kidney disease and obesity: healthy lifestyles for healthy kidneys’, highlighting the crucial link between the kidneys and metabolic and cardiovascular health. In April, the Global Kidney Health Atlas, one of the largest health-related country capacity reviews in history, was launched at the World Congress of Nephrology in Mexico City. The Atlas, a first for the nephrology community, is a multinational cross-sectional survey designed to assess need and capacity for kidney care worldwide and provide the foundation for a global surveillance network for chronic kidney disease (CKD) care. CKD is an enormous public health issue, the tide of which continues to inexorably rise. In the 2015 Global Burden of Disease Study, kidney disease was the 12th most common cause of death, accounting for 1.1 million deaths worldwide.1 Overall CKD mortality has increased by 31.7% over the last 10 years, making it one of the fastest rising major causes of death, alongside diabetes and dementia.1 In the same study, CKD ranked as the 17th leading cause of global years lost of life, an 18.4% increase since 2005, and the third largest increase of any major cause of death.1 This is in stark contrast to other non-communicable diseases, for example cardiovascular disease and chronic obstructive pulmonary disease, where global years lost of life fell during the same time period (−10.2% and −3.0%, respectively).1 Unabated growth in the incidence of diabetic kidney disease, underpinned by a global imbalance between overnutrition and inadequate physical inactivity causing overweight and obesity, is the key driver of CKD burden. Between 2005 and 2015, the prevalence of diabetic kidney disease increased by 39.5% globally.1 In Mexico, the country with the highest CKD death rate in the world, …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173515 · Cited by 141 · cited 1×
“As highlighted by World Kidney Day, obesity is a significant marker of risk for CKD, independent of hypertension and diabetes, and therefore represents another important target for CKD screening and early detection.(7) There is evidence that weight reduction in CKD reduces proteinuria and blood pressure and may slow d…”
Background
Research works printed but not linked: 8
- Tonelli, 2014, How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program, Kidney Int, 85, 1269, 10.1038/ki.2012.488 · DOI
- Anand, 2017, Prevalence of chronic kidney disease and risk factors for its progression: a cross-sectional comparison of Indians living in indian versus U.S. cities, PLoS One, 12, 10.1371/journal.pone.0173554 · DOI
- 10.1016/S0140-6736(14)61601-9 · DOI · Paper page
- Thomas B , Matsushita K , Abate KH , et al . Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol 2017:ASN.2016050562. [Epub ahead of print].doi:10.1681/ASN.2016050562 · DOI · Paper page
- 10.2215/CJN.02250409 · DOI · Paper page
- Bello AK JD , Feehally J , Harris D , et al . Global Kidney Health Atlas (GKHA): Design and Methods. Kidney International. In Press. 2017. · DOI
- Bello, 2017, Assessment of Global Kidney Health Care Status, JAMA, 317, 1864, 10.1001/jama.2017.4046 · DOI · Paper page
- 10.1136/bmj.h6704 · DOI · Paper page
Cited by
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Self-citationEpidemiology of haemodialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00542-7 · Cited by 631
Self-citation
Metadata
- Authors
- Neuen, B. L., Chadban, S. J., Demaio, A. R., Johnson, D. W., & Perkovic, V.
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2017-07
- Volume
- 2
- Issue
- 2
- Pages
- e000380
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W2726491114
- Cited by
- 246
- References
- 5
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic kidney disease and the global NCDs agenda. https://app.cochat.ai/papers/10.1136/bmjgh-2017-000380
- The paper
- Neuen, B. L., Chadban, S. J., Demaio, A. R., Johnson, D. W., & Perkovic, V. (2017). Chronic kidney disease and the global NCDs agenda. BMJ Global Health. https://doi.org/10.1136/bmjgh-2017-000380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.